In the last 12 months, insiders at Oruka Therapeutics, Inc. ($ORKA) filed 83 transactions with the SEC: 5 open-market purchases totaling $1,407,368 and 21 sales totaling $1,657,506. Net insider sentiment: net selling.
Oruka Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Fairmount Funds Management LLC (Director) — 6 transactions totaling $11,348,100
- Venrock Healthcare Capital Partners III, L.P. (Not found) — 5 transactions totaling $1,407,368
- Goncalves Joana (Chief Medical Officer) — 31 transactions totaling $1,181,076
- Sandler Laura Lee (Chief Operating Officer) — 13 transactions totaling $641,397
- Klein Lawrence Otto (Chief Executive Officer) — 4 transactions totaling $71,408
View all SEC Filings for Oruka Therapeutics, Inc. (ORKA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Klein Lawrence Otto | Chief Executive Officer | S | Common Stock | 1729 | $41.30 | 927,309.0000 | 42,095,951 | 0.19% | 0.00% |
| March 16, 2026 | Agarwal Arjun | Senior Vice President, Finance | S | Common Stock | 395 | $41.30 | 18,863.0000 | 42,095,951 | 2.05% | 0.00% |
| March 16, 2026 | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 600 | $41.30 | 236,984.0000 | 42,095,951 | 0.25% | 0.00% |
| March 16, 2026 | Goncalves Joana | Chief Medical Officer | M | Common Stock | 3500 | $6.84 | 37,518.0000 | 42,095,951 | 10.29% | 0.01% |
| March 16, 2026 | Goncalves Joana | Chief Medical Officer | M | Common Stock | 3500 | $7.80 | 41,018.0000 | 42,095,951 | 9.33% | 0.01% |
| March 16, 2026 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 2921 | $40.11 | 38,097.0000 | 42,095,951 | 7.12% | 0.01% |
| March 16, 2026 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 2902 | $41.20 | 35,195.0000 | 42,095,951 | 7.62% | 0.01% |
| March 16, 2026 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 1177 | $41.94 | 34,018.0000 | 42,095,951 | 3.34% | 0.00% |
| March 16, 2026 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 641 | $41.30 | 33,377.0000 | 42,095,951 | 1.88% | 0.00% |
| March 16, 2026 | Goncalves Joana | Chief Medical Officer | M | Employee Stock Option (right to buy) | 3500 | $0.00 | 214,563.0000 | 42,095,951 | 1.61% | 0.01% |
| March 16, 2026 | Goncalves Joana | Chief Medical Officer | M | Employee Warrant (right to buy) | 3500 | $0.00 | 185,992.0000 | 42,095,951 | 1.85% | 0.01% |
| March 16, 2026 | Quinlan Paul T | General Counsel | S | Common Stock | 733 | $41.30 | 31,767.0000 | 42,095,951 | 2.26% | 0.00% |
| March 2, 2026 | Sandler Laura Lee | Chief Operating Officer | M | Employee Warrant (right to buy) | 5000 | $0.00 | 89,996.0000 | 42,095,951 | 5.26% | 0.01% |
| March 2, 2026 | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 2675 | $33.81 | 237,584.0000 | 42,095,951 | 1.11% | 0.01% |
| March 2, 2026 | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 2325 | $33.28 | 240,259.0000 | 42,095,951 | 0.96% | 0.01% |
| March 2, 2026 | Sandler Laura Lee | Chief Operating Officer | M | Common Stock | 5000 | $7.80 | 242,584.0000 | 42,095,951 | 2.10% | 0.01% |
| Feb. 17, 2026 | Goncalves Joana | Chief Medical Officer | M | Employee Warrant (right to buy) | 3500 | $0.00 | 189,492.0000 | 42,095,951 | 1.81% | 0.01% |
| Feb. 17, 2026 | Goncalves Joana | Chief Medical Officer | M | Employee Stock Option (right to buy) | 3500 | $0.00 | 218,063.0000 | 42,095,951 | 1.58% | 0.01% |
| Feb. 17, 2026 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 936 | $32.78 | 34,018.0000 | 42,095,951 | 2.68% | 0.00% |
| Feb. 17, 2026 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 6064 | $32.30 | 34,954.0000 | 42,095,951 | 14.78% | 0.01% |
| Feb. 17, 2026 | Goncalves Joana | Chief Medical Officer | M | Common Stock | 3500 | $7.80 | 41,018.0000 | 42,095,951 | 9.33% | 0.01% |
| Feb. 17, 2026 | Goncalves Joana | Chief Medical Officer | M | Common Stock | 3500 | $6.84 | 37,518.0000 | 42,095,951 | 10.29% | 0.01% |
| Jan. 23, 2026 | Dambkowski Carl | Director | J | Common Stock | 116483 | $0.00 | 116,483.0000 | 42,095,951 | 9999.99% | 0.28% |
| Jan. 23, 2026 | Goncalves Joana | Chief Medical Officer | A | Common Stock | 32500 | $0.00 | 34,018.0000 | 42,095,951 | 2140.98% | 0.08% |
| Jan. 23, 2026 | Goncalves Joana | Chief Medical Officer | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 42,095,951 | 9999.99% | 0.31% |
| Jan. 23, 2026 | Sandler Laura Lee | Chief Operating Officer | A | Common Stock | 32500 | $0.00 | 237,584.0000 | 42,095,951 | 15.85% | 0.08% |
| Jan. 23, 2026 | Sandler Laura Lee | Chief Operating Officer | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 42,095,951 | 9999.99% | 0.31% |
| Jan. 23, 2026 | Agarwal Arjun | SVP, Finance | A | Common Stock | 17500 | $0.00 | 19,258.0000 | 42,095,951 | 995.45% | 0.04% |
| Jan. 23, 2026 | Agarwal Arjun | SVP, Finance | A | Employee Stock Option (right to buy) | 70000 | $0.00 | 70,000.0000 | 42,095,951 | 9999.99% | 0.17% |
| Jan. 23, 2026 | Klein Lawrence Otto | Chief Executive Officer | A | Common Stock | 76700 | $0.00 | 929,038.0000 | 42,095,951 | 9.00% | 0.18% |
| Jan. 23, 2026 | Klein Lawrence Otto | Chief Executive Officer | A | Employee Stock Option (right to buy) | 306700 | $0.00 | 306,700.0000 | 42,095,951 | 9999.99% | 0.73% |
| Jan. 23, 2026 | Quinlan Paul T | General Counsel | A | Common Stock | 32500 | $0.00 | 32,500.0000 | 42,095,951 | 9999.99% | 0.08% |
| Jan. 23, 2026 | Quinlan Paul T | General Counsel | A | Employee Stock Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 42,095,951 | 9999.99% | 0.31% |
| Jan. 15, 2026 | Goncalves Joana | Chief Medical Officer | M | Employee Stock Option (right to buy) | 3500 | $0.00 | 221,563.0000 | 42,095,951 | 1.56% | 0.01% |
| Jan. 15, 2026 | Goncalves Joana | Chief Medical Officer | M | Employee Warrant (right to buy) | 3500 | $0.00 | 192,992.0000 | 42,095,951 | 1.78% | 0.01% |
| Jan. 15, 2026 | Goncalves Joana | Chief Medical Officer | M | Common Stock | 3500 | $6.84 | 5,018.0000 | 42,095,951 | 230.57% | 0.01% |
| Jan. 15, 2026 | Goncalves Joana | Chief Medical Officer | M | Common Stock | 3500 | $7.80 | 8,518.0000 | 42,095,951 | 69.75% | 0.01% |
| Jan. 15, 2026 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 4381 | $31.56 | 4,137.0000 | 42,095,951 | 51.43% | 0.01% |
| Jan. 15, 2026 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 2619 | $32.24 | 1,518.0000 | 42,095,951 | 63.31% | 0.01% |
| Jan. 2, 2026 | Sandler Laura Lee | Chief Operating Officer | M | Employee Warrant (right to buy) | 5000 | $0.00 | 94,996.0000 | 42,095,951 | 5.00% | 0.01% |
| Jan. 2, 2026 | Sandler Laura Lee | Chief Operating Officer | M | Common Stock | 5000 | $7.80 | 218,084.0000 | 42,095,951 | 2.35% | 0.01% |
| Jan. 2, 2026 | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 8748 | $28.17 | 209,336.0000 | 42,095,951 | 4.01% | 0.02% |
| Jan. 2, 2026 | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 3144 | $29.08 | 206,192.0000 | 42,095,951 | 1.50% | 0.01% |
| Jan. 2, 2026 | Sandler Laura Lee | Chief Operating Officer | S | Common Stock | 1108 | $29.75 | 205,084.0000 | 42,095,951 | 0.54% | 0.00% |
| Dec. 19, 2025 | Goncalves Joana | Chief Medical Officer | M | Common Stock | 3500 | $6.84 | 5,018.0000 | 42,095,951 | 230.57% | 0.01% |
| Dec. 19, 2025 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 641 | $28.53 | 7,877.0000 | 42,095,951 | 7.53% | 0.00% |
| Dec. 19, 2025 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 1787 | $29.62 | 6,090.0000 | 42,095,951 | 22.69% | 0.00% |
| Dec. 19, 2025 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 1492 | $30.70 | 4,598.0000 | 42,095,951 | 24.50% | 0.00% |
| Dec. 19, 2025 | Goncalves Joana | Chief Medical Officer | S | Common Stock | 3080 | $31.58 | 1,518.0000 | 42,095,951 | 66.99% | 0.01% |
| Dec. 19, 2025 | Goncalves Joana | Chief Medical Officer | M | Employee Stock Option (right to buy) | 3500 | $0.00 | 225,063.0000 | 42,095,951 | 1.53% | 0.01% |
| Dec. 19, 2025 | Goncalves Joana | Chief Medical Officer | M | Employee Warrant (right to buy) | 3500 | $0.00 | 196,492.0000 | 42,095,951 | 1.75% | 0.01% |
| Dec. 19, 2025 | Goncalves Joana | Chief Medical Officer | M | Common Stock | 3500 | $7.80 | 8,518.0000 | 42,095,951 | 69.75% | 0.01% |
| Dec. 11, 2025 | Martin Christopher Nathan | Director | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 42,095,951 | 9999.99% | 0.08% |
| Sept. 17, 2025 | Fairmount Funds Management LLC | Director | A | Common Stock | 333340 | $15.00 | 3,705,262.0000 | 42,095,951 | 9.89% | 0.79% |
| July 1, 2025 | Sandler Laura Lee | Chief Operating Officer | A | Employee Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 42,095,951 | 9999.99% | 0.06% |
| June 2, 2025 | Dambkowski Carl | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 41,679,560 | 9999.99% | 0.04% |
| June 2, 2025 | BALL KRISTINE M | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 41,679,560 | 9999.99% | 0.04% |
| June 2, 2025 | Fairmount Funds Management LLC | Director | A | Stock Option (Right to Buy) | 17500 | $0.00 | 17,500.0000 | 41,679,560 | 9999.99% | 0.04% |
| June 2, 2025 | Kulkarni Samarth | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 41,679,560 | 9999.99% | 0.04% |
| June 2, 2025 | Turtle Cameron | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 41,679,560 | 9999.99% | 0.04% |
| Feb. 11, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 9593 | $10.95 | 4,035,713.0000 | 16,789,362 | 0.24% | 0.06% |
| Feb. 14, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 88794 | $11.44 | 4,148,428.0000 | 16,789,362 | 2.19% | 0.53% |
| Feb. 13, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 14950 | $11.63 | 4,059,634.0000 | 16,789,362 | 0.37% | 0.09% |
| Feb. 12, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 8971 | $11.86 | 4,044,684.0000 | 16,789,362 | 0.22% | 0.05% |
| Feb. 10, 2025 | Venrock Healthcare Capital Partners III, L.P. | Not found | P | Common Stock | 574 | $10.90 | 4,026,120.0000 | 16,789,362 | 0.01% | 0.00% |
| Jan. 22, 2025 | Klein Lawrence Otto | Chief Executive Officer | A | Employee Stock Option (right to buy) | 230000 | $0.00 | 230,000.0000 | 16,789,362 | 9999.99% | 1.37% |
| Jan. 22, 2025 | Agarwal Arjun | SVP, Finance | A | Employee Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 16,789,362 | 9999.99% | 0.71% |
| Jan. 22, 2025 | Goncalves Joana | Chief Medical Officer | A | Employee Stock Option (right to buy) | 162500 | $0.00 | 162,500.0000 | 16,789,362 | 9999.99% | 0.97% |
| Jan. 22, 2025 | Quinlan Paul T | General Counsel | A | Employee Stock Option (right to buy) | 162500 | $0.00 | 162,500.0000 | 16,789,362 | 9999.99% | 0.97% |
| Nov. 19, 2024 | Fairmount Funds Management LLC | Director | M | Series A Non-Voting Convertible Preferred Stock | 160 | $0.00 | 0.0000 | 15,013,655 | 100.00% | 0.00% |
| Nov. 19, 2024 | Fairmount Funds Management LLC | Director | M | Common Stock | 160000 | $0.00 | 3,371,922.0000 | 15,013,655 | 4.98% | 1.07% |
| Sept. 11, 2024 | Fairmount Funds Management LLC | Director | A | Common Stock | 275000 | $23.00 | 3,211,922.0000 | 3,197,975 | 9.36% | 8.60% |
| Sept. 11, 2024 | Fairmount Funds Management LLC | Director | A | Series A Non-Voting Convertible Preferred Stock | 160 | $23000.00 | 160.0000 | 3,197,975 | 9999.99% | 0.01% |
| Aug. 29, 2024 | Ma-Weaver Jacob | Other | J | Stock option (right to buy) | 6000 | $0.00 | 0.0000 | 3,197,975 | 100.00% | 0.19% |
| Aug. 29, 2024 | Ma-Weaver Jacob | Other | J | Stock option (right to buy) | 6000 | $0.00 | 0.0000 | 3,197,975 | 100.00% | 0.19% |
| Aug. 29, 2024 | Ma-Weaver Jacob | Other | J | Stock option (right to buy) | 12000 | $0.00 | 0.0000 | 3,197,975 | 100.00% | 0.38% |
| Jan. 30, 2024 | CONWAY ROBERT E | Other | A | Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 14,415,877 | 9999.99% | 0.04% |
| Jan. 30, 2024 | MITCHELL DANIEL J | Director | A | Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 14,415,877 | 9999.99% | 0.04% |
| Jan. 30, 2024 | Hove Anders D | Director | A | Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 14,415,877 | 9999.99% | 0.04% |
| Jan. 30, 2024 | Ma-Weaver Jacob | Other | A | Stock option (right to buy) | 6000 | $0.00 | 6,000.0000 | 14,415,877 | 9999.99% | 0.04% |
| Jan. 30, 2024 | Woosley Raymond L. | Director | A | Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 14,415,877 | 9999.99% | 0.04% |
| Jan. 30, 2024 | Grais Linda | Director | A | Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 14,415,877 | 9999.99% | 0.04% |
| Jan. 30, 2024 | Flynn James P | Director | A | Stock Option (right to buy) | 6000 | $0.00 | 6,000.0000 | 14,415,877 | 9999.99% | 0.04% |